Please Wait...

BioClinica Acquires Blueprint Clinical, Inc.

– eClinical Leader adds Risk-Based Monitoring Technology to Platform –

June 16, 2014

BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials. This move adds Compass, a cloud-based site scoring tool to the robust BioClinica eClinical platform.

By combining the Compass technology with its experience in clinical trial management, BioClinica will now offer a comprehensive "Intelligent Monitoring" solution which will enable pharmaceutical companies and contract research organizations (CROs) to embrace the reduced source documentation approach outlined by the FDA.

BioClinica President and Chief Executive Officer Mark Weinstein said, "Ever since the FDA issued its final guidance to industry on risk-based monitoring last year, there's been an explosion of interest in technology to make it a reality. Compass provides a transformative risk-based monitoring solution that enables the industry to move forward."

President and Co-founder of Blueprint Clinical, Courtney McBean added, "Compass is a powerful and proven tool that enables you to monitor what matters, when it matters. It's an intelligent monitoring solution that replaces 100 percent source data verification with greater use of off-site and central monitoring."

Compass is used to evaluate potential risks to patient safety and clinical trial operational performance. It assigns a performance-based score to each investigative site based on a combination of quantitative data and qualitative information. It is flexible and adaptable to each sponsors' needs and is responsive to the complex and dynamic nature of clinical trial designs. Compass accounts for factors unique to the study protocol and investigational drug. Compass provides information that enables sponsors and CROs to adjust their monitoring and focus attention on those sites needing extra support. Among the benefits of using Compass are optimized site quality performance, reduced costs, and effective use of monitoring resources.

Compass leverages data from a sponsor's existing Electronic Data Capture (EDC) and Clinical Trial Management System (CTMS) whether BioClinica Express, OnPoint, or other eClinical systems. This extends the value of sponsors' existing investments while supporting integrated monitoring without redundant data collection.

McBean, who will be joining BioClinica with her team to direct Compass implementation remarked, "I am thrilled that the Compass technology is now part of BioClinica's exceptional eClinical Platform."

BioClinica is excited to add the Compass product to their Best-in-class eClinical Solutions, including:

  • Express EDC: Electronic Data Capture in a web-based solution that creates efficient processes while capturing clean real-time data at the source. Express includes tools for fast-track study build and change management, deep operational visibility, and targeted monitoring.
  • OnPoint CTMS: The Office-Smart Clinical Trial Management System that leverages Microsoft applications for the ultimate CTMS experience. It aligns clinical operations and business processes for end-to-end efficiency across the entire trial lifecycle. It provides large-scale user access without expensive licensing fees.  
  • Optimizer:   Powerful forecasting, simulation and demand planning technology for managing global logistics of the clinical supply chain. Optimizer Enterprise Suite includes a streamlined cloud-based tool for essential modeling and planning, a robust desktop solution for extended forecasting and planning, and Aggregator for enterprise demand planning and visibility into the global supply chain.
  • Trident IRT:    The parameter-driven IRT with unprecedented performance and functionality. It  accelerate study protocol setup and deployment and enables study personnel to accomplish complex subject randomization and drug dosing, tracking and reconciliation using a single powerful tool.

Industry professionals can get a first-hand look at Compass and BioClinica's other eClinical Solutions and Medical Imaging and Cardiac Safety services at the Drug Information Association (DIA) Annual Meeting. BioClinica will provide demonstrations in its exhibit in Booth 1725 at the San Diego Convention Center until June 18.

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

In a new go-to-guide on #Alzheimer's clin trials, experts Marieke Cajal, Joyce Suhy, Luc Bracoud, Mette Skaksen &… https://t.co/gSknj8EsuV
bioclinica (2 days ago)
Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technolo… https://t.co/Oy08iB9hLO
bioclinica (2 days ago)
We've re-vamped our website to make it easier to navigate Bioclinica Site Network online. Check it out! https://t.co/iyvZouesjV
bioclinica (3 days ago)
RT @Clin_Trials: Latest Business and People #News featuring @bioclinica, @clinipace, @InClinica, @PAREXEL, and more! https://t.co/0qBrc36mh…
bioclinica (3 days ago)
RT @ArenaIntPharma: Check out some of our Session Sponsors for this year's Clinical Operations in Oncology Trials East Coast 2018! @bioclin…
bioclinica (3 days ago)
A great Day 2 in Barcelona at #OCTEurope. Visit @bioclinica for the latest on science & technology-enabled clinical… https://t.co/uJwBEt580C
bioclinica (4 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen